Jianrong Wu

6PUBLICATIONS
1CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2021
Bayesian single-arm phase II trial designs with time-to-event endpoints.

Jianrong Wu, Haitao Pan, Chia-Wei Hsu

|Sep 02, 2020
Cancer immunotherapy trial design with long-term survivors.

Xue Ding, Jianrong Wu

|Feb 25, 2020
Designing cancer immunotherapy trials with delayed treatment effect using maximin efficiency robust statistics.

Xue Ding, Jianrong Wu

|Nov 22, 2019
Two-stage phase II survival trial design.

Jianrong Wu, Li Chen, Jing Wei

|Nov 16, 2019
Cancer immunotherapy trial design with delayed treatment effect.

Jianrong Wu, Jing Wei

|Nov 21, 2018
Phase II trial design with growth modulation index as the primary endpoint.

Jianrong Wu, Li Chen, Jing Wei

Pageof 1

Frequent Collaborators

1 joint publications

Haitao Pan